Sharps Technology, Inc. (NASDAQ: STSS) recently announced that the Company will be commercializing cutting-edge prefillable syringe system products to provide new solutions to customers in the ...

Sharps Technology Inc. (NASDAQ: STSS) is pushing into the copolymer prefillable syringe market thanks to a deal with Nephron Pharmaceuticals Corp., a leader in contract manufacturing of generic ...

Signed PO secures first 12 months of syringe product orders against Sharps and Nephron’s five-year, $200 million Syringe Sales Agreement. Current Asset Purchase Agreement closing timeline is on track ...

Medical device company Sharps Technology Inc. (NASDAQ: STSS) is taking stock as it approaches one year since its initial public offering (IPO). Since its IPO, the company has taken major strides in ...

The addition of two new sharps disposal boxes add to the effort of offering proper disposal of needles, lancets, syringes and ...

Sharps CEO issues letter to shareholders with details about the InjectEZ acquisition, establishing Sharps position in the prefillable syringe (PFS) industry in the U.S. Signed Syringe Sales Agreement ...

Shares of Sharps Technology Inc (NASDAQ:STSS) are trading higher on Friday, with a heavy session volume of 15.17 million. On Wednesday, the medical device and pharmaceutical packaging company received ...

Dynarex has debuted four new products geared toward safety. The SecureSafe™ Safety Syringes have an enhanced safety mechanism and include insulin safety syringes and allergy safety syringe trays. The ...

Sharps Technology, Inc. STSS STSSW announced the advancement of the Company's specialized prefillable syringe ("PFS") system product line, which will be manufactured in collaboration with Nephron ...

Definitive agreement sells out the 10mL SoloGard production capacity at Sharps’ manufacturing site in the EU and drives expansion to support the project’s growth in the future Sharps’ portfolio of ...